ANI Pharmaceuticals, Inc. Net Income 2009–2025
ANI Pharmaceuticals, Inc. reported $77.18M of net income for fiscal 2025. That was 483.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +442.3%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $77.18M | 8.7% | +483.1% |
| FY 2024 | $-20.15M | -3.3% | -217.4% |
| FY 2023 | $17.15M | 3.5% | +134.6% |
| FY 2022 | $-49.52M | -15.7% | -16.2% |
| FY 2021 | $-42.60M | -19.7% | -88.9% |
| FY 2020 | $-22.55M | -10.8% | -470.0% |
| FY 2019 | $6.09M | 3.0% | -60.7% |
| FY 2018 | $15.49M | 7.7% | +1540.0% |
| FY 2017 | $-1.08M | -0.6% | -127.4% |
| FY 2016 | $3.93M | 3.1% | -74.4% |
| FY 2015 | $15.38M | 20.1% | -46.5% |
| FY 2014 | $28.75M | 51.4% | +9450.5% |
| FY 2013 | $301,000 | 1.0% | +120.0% |
| FY 2012 | $-1.51M | -7.4% | — |
| FY 2011 | $0 | 0.0% | — |
| FY 2010 | $0 | 0.0% | — |
| FY 2009 | $0 | 0.0% | — |
Source: ANI Pharmaceuticals, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ANIP 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ANI Pharmaceuticals, Inc. reported $77.18M of net income for fiscal 2025. That was 483.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +442.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ANI Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeANI Pharmaceuticals, Inc. — frequently asked questions
What is ANI Pharmaceuticals, Inc.'s net income?
ANI Pharmaceuticals, Inc. (ANIP) reported net income of $77.18M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ANI Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.